{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:42:44Z","timestamp":1784259764935,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T00:00:00Z","timestamp":1563408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aims of this systematic review are to refine the catalogue of somatic variants in splenic marginal zone lymphoma (SMZL) and to provide a well-annotated, manually curated database of high-confidence somatic mutations to facilitate variant interpretation for further biological studies and future clinical implementation. Two independent reviewers systematically searched PubMed and Ovid in January 2019 and included studies that sequenced SMZL cases with confirmed diagnosis. The database included fourteen studies, comprising 2817 variants in over 1000 genes from 475 cases. We confirmed the high prevalence of <jats:italic>NOTCH2, KLF2<\/jats:italic> and <jats:italic>TP53<\/jats:italic> mutations and analysis of targeted genes further implicated <jats:italic>TNFAIP3<\/jats:italic>, <jats:italic>KMT2D<\/jats:italic>, and <jats:italic>TRAF3<\/jats:italic> as recurrent targets of somatic mutation based on their high incidence across studies. The major limitations we encountered were the low number of patients with whole-genome, unbiased analysis and the relative sensitivities of differing sequencing approaches. Overall, we showed that there is little concordance between whole exome sequencing studies of SMZL. We strongly support the continuing unbiased analysis of the SMZL genome for mutations in all protein-coding genes and provide a valuable database resource to facilitate this endeavour that will ultimately improve our understanding of SMZL pathobiology.<\/jats:p>","DOI":"10.1038\/s41598-019-46906-1","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T10:02:38Z","timestamp":1563444158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Carolina","family":"Jaramillo Oquendo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oscier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0973-8285","authenticated-orcid":false,"given":"Jane","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-2881","authenticated-orcid":false,"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,18]]},"reference":[{"key":"46906_CR1","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1084\/jem.20120910","volume":"209","author":"MJ Kiel","year":"2012","unstructured":"Kiel, M. J. et al. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209, 1553\u20131565 (2012).","journal-title":"J. Exp. Med."},{"key":"46906_CR2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20120904","volume":"209","author":"D Rossi","year":"2012","unstructured":"Rossi, D. et al. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J. Exp. Med. 209, 1537\u20131551 (2012).","journal-title":"J. Exp. Med."},{"key":"46906_CR3","first-page":"1","volume":"8","author":"M Parry","year":"2013","unstructured":"Parry, M. et al. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma. PLoS One 8, 1\u20135 (2013).","journal-title":"PLoS One"},{"key":"46906_CR4","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/leu.2013.365","volume":"28","author":"N Mart\u00ednez","year":"2014","unstructured":"Mart\u00ednez, N. et al. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation. Leukemia 28, 1334\u20131340 (2014).","journal-title":"Leukemia"},{"key":"46906_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1766-z","volume":"15","author":"J Peveling-Oberhag","year":"2015","unstructured":"Peveling-Oberhag, J. et al. Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations. BMC Cancer 15, 773 (2015).","journal-title":"BMC Cancer"},{"key":"46906_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/leu.2014.330","volume":"29","author":"A Clipson","year":"2015","unstructured":"Clipson, A. et al. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype. Leukemia 29, 1177\u20131185 (2015).","journal-title":"Leukemia"},{"key":"46906_CR7","first-page":"4930","volume":"118","author":"D Rossi","year":"2011","unstructured":"Rossi, D. et al. Brief report Alteration of BIRC3 and multiple other NF- B pathway genes in splenic marginal zone lymphoma. Gene 118, 4930\u20134934 (2011).","journal-title":"Gene"},{"key":"46906_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3324\/haematol.2011.054080","volume":"97","author":"Q Yan","year":"2012","unstructured":"Yan, Q. et al. BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas. Haematologica 97, 595\u2013598 (2012).","journal-title":"Haematologica"},{"key":"46906_CR9","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","volume":"21","author":"M Parry","year":"2015","unstructured":"Parry, M. et al. Genetics and prognostication in splenic marginal zone lymphoma: Revelations from deep sequencing. Clin. Cancer Res. 21, 4174\u20134183 (2015).","journal-title":"Clin. Cancer Res."},{"key":"46906_CR10","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/leu.2014.294","volume":"29","author":"R Piva","year":"2015","unstructured":"Piva, R. et al. The Kr\u00fcppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma. Leukemia 29, 503\u2013507 (2015).","journal-title":"Leukemia"},{"key":"46906_CR11","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","volume":"128","author":"V Spina","year":"2016","unstructured":"Spina, V. et al. The Genetics of Nodal Marginal Zone Lymphoma. Blood 128, 1362\u20131374 (2016).","journal-title":"Blood"},{"key":"46906_CR12","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.3324\/haematol.2016.161711","volume":"102","author":"Y Campos-Mart\u00edn","year":"2017","unstructured":"Campos-Mart\u00edn, Y. et al. Clinical and diagnostic relevance of NOTCH2 and KLF2 mutations in splenic marginal zone lymphoma. Haematologica 102, e310\u2013e312 (2017).","journal-title":"Haematologica"},{"key":"46906_CR13","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.3324\/haematol.2016.160192","volume":"102","author":"L Jallades","year":"2017","unstructured":"Jallades, L. et al. Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica 102, 1758\u20131766 (2017).","journal-title":"Haematologica"},{"key":"46906_CR14","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","volume":"32","author":"V Pillonel","year":"2018","unstructured":"Pillonel, V. et al. High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations. Leukemia 32, 2412\u20132426 (2018).","journal-title":"Leukemia"},{"key":"46906_CR15","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"46906_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"P Jain","year":"2014","unstructured":"Jain, P. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet."},{"key":"46906_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/humu.23035","volume":"37","author":"G Byrnes","year":"2016","unstructured":"Byrnes, G. et al. TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data. Hum. Mutat. 37, 865\u2013876 (2016).","journal-title":"Hum. Mutat."},{"key":"46906_CR18","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2017","unstructured":"Landrum, M. J. et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2017).","journal-title":"Nucleic Acids Res."},{"key":"46906_CR19","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1182\/blood-2013-09-525808","volume":"123","author":"ZR Hunter","year":"2014","unstructured":"Hunter, Z. R. et al. The genomic landscape of Waldenstr\u00f6m macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. Blood 123, 1637\u20131646 (2014).","journal-title":"Blood"},{"key":"46906_CR20","first-page":"1199","volume":"123","author":"A Athanasiadou","year":"2013","unstructured":"Athanasiadou, A. et al. Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity? Blood 123, 1199\u20131206 (2013).","journal-title":"Blood"},{"key":"46906_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.beha.2016.08.028","volume":"30","author":"A Xochelli","year":"2017","unstructured":"Xochelli, A., Oscier, D. & Stamatopoulos, K. Clonal B-cell lymphocytosis of marginal zone origin. Best Pract. Res. Clin. Haematol. 30, 77\u201383 (2017).","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"46906_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/bloodadvances.2018019760","volume":"2","author":"H Parker","year":"2018","unstructured":"Parker, H. et al. CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up. Blood Adv. 2, 1116\u20131119 (2018).","journal-title":"Blood Adv."},{"key":"46906_CR23","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes, S. A. et al. COSMIC: Somatic cancer genetics at high-resolution. Nucleic Acids Res. 45, D777\u2013D783 (2017).","journal-title":"Nucleic Acids Res."},{"key":"46906_CR24","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","volume":"129","author":"S Curiel-Olmo","year":"2017","unstructured":"Curiel-Olmo, S. et al. Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations. Blood 129, 1042\u20131045 (2017).","journal-title":"Blood"},{"key":"46906_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-1114-x","volume":"17","author":"S Canisius","year":"2016","unstructured":"Canisius, S., Martens, J. W. M. & Wessels, L. F. A. A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence. Genome Biol. 17, 1\u201317 (2016).","journal-title":"Genome Biol."},{"key":"46906_CR26","unstructured":"ICGC. Study Design and Statistical Issues. International Cancer Genome Consortium: Goals, Structures, Policies, and Guidelines (2010)."},{"key":"46906_CR27","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1158\/1078-0432.CCR-14-1348","volume":"21","author":"K Wang","year":"2015","unstructured":"Wang, K. et al. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a \u03b3-secretase inhibitor. Clin. Cancer Res. 21, 1487\u20131496 (2015).","journal-title":"Clin. Cancer Res."},{"key":"46906_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/nm.3943","volume":"21","author":"A Ortega-Molina","year":"2015","unstructured":"Ortega-Molina, A. et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat. Med. 21, 1199\u20131208 (2015).","journal-title":"Nat. Med."},{"key":"46906_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9866","volume":"6","author":"S Kasar","year":"2015","unstructured":"Kasar, S. et al. Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution. Nat. Commun. 6, 1\u201312 (2015).","journal-title":"Nat. Commun."},{"key":"46906_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","volume":"135","author":"DF Robbiani","year":"2008","unstructured":"Robbiani, D. F. et al. AID Is Required for the Chromosomal Breaks in c-myc that Lead to c-myc\/IgH Translocations. Cell 135, 1028\u20131038 (2008).","journal-title":"Cell"},{"key":"46906_CR31","doi-asserted-by":"crossref","unstructured":"Shamseer, L. et al. Preferred reporting items for systematic review and and explanation meta-analysis protocols (PRISMA-P) 2015: elaboration. BJM 1\u201325 (2015).","DOI":"10.1136\/bmj.g7647"},{"key":"46906_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher, D. et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst. Rev. 4, 1 (2015).","journal-title":"Syst. Rev."},{"key":"46906_CR33","doi-asserted-by":"crossref","unstructured":"Liberati, A. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med. 6, (2009).","DOI":"10.1371\/journal.pmed.1000100"},{"key":"46906_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl Variant Effect Predictor. Genome Biol. 17, 1\u201314 (2016).","journal-title":"Genome Biol."},{"key":"46906_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkp829","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, 1\u20137 (2010).","journal-title":"Nucleic Acids Res."},{"key":"46906_CR36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nat. Publ. Gr. 536, 285\u2013291 (2016).","journal-title":"Nat. Publ. Gr."},{"key":"46906_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"G Project","year":"2015","unstructured":"Project, G. et al. A global reference for human genetic variation. Nature 526, 68\u201374 (2015).","journal-title":"Nature"},{"key":"46906_CR38","unstructured":"Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP). Available at, http:\/\/evs.gs.washington.edu\/EVS\/ (Accessed: 2nd February 2019)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46906-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46906-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46906-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:41:18Z","timestamp":1671277278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46906-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,18]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46906"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46906-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,18]]},"assertion":[{"value":"11 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10444"}}